CD24 and neoplasm: Examination of the injection sites where CD44+/CD24+/ESA+ and CD44+/CD24-//ESA- cells were unable to form tumors revealed viable cells and Matrigel at the site of injection (data not shown), confirming that lack of tumor growth from these cells was not due to clearing or cell death.